Luisa Verga

1.4k total citations
33 papers, 288 citations indexed

About

Luisa Verga is a scholar working on Oncology, Infectious Diseases and Pathology and Forensic Medicine. According to data from OpenAlex, Luisa Verga has authored 33 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 12 papers in Infectious Diseases and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Luisa Verga's work include Lymphoma Diagnosis and Treatment (12 papers), Neutropenia and Cancer Infections (10 papers) and Viral-associated cancers and disorders (10 papers). Luisa Verga is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Neutropenia and Cancer Infections (10 papers) and Viral-associated cancers and disorders (10 papers). Luisa Verga collaborates with scholars based in Italy, Russia and Malaysia. Luisa Verga's co-authors include Matteo Parma, Elisabetta Terruzzi, Chiara Cattaneo, Enrico Maria Pogliani, Fernando Ravagnani, Patrizia Accorsi, A Iacone, Alessandro Busca, Luisa Tavecchia and Paolo Perseghin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Luisa Verga

27 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luisa Verga Italy	10	143	122	103	77	35	33	288
Angelika Valentin Austria	7	49 0.3×	125 1.0×	111 1.1×	80 1.0×	14 0.4×	12	313
Paula Yurie Tanaka Brazil	9	168 1.2×	64 0.5×	35 0.3×	62 0.8×	56 1.6×	20	286
Mariagrazia Garzia Italy	8	51 0.4×	68 0.6×	47 0.5×	76 1.0×	31 0.9×	19	201
L. S. Zubarovskaya Russia	9	62 0.4×	64 0.5×	78 0.8×	126 1.6×	23 0.7×	140	297
Jennifer Holter Chakrabarty United States	5	95 0.7×	56 0.5×	43 0.4×	45 0.6×	16 0.5×	13	193
Angela Haßler Germany	8	60 0.4×	225 1.8×	103 1.0×	33 0.4×	126 3.6×	9	377
Giorgia Battipaglia France	10	122 0.9×	55 0.5×	78 0.8×	211 2.7×	12 0.3×	16	320
Maria Elena Zannier Italy	8	40 0.3×	53 0.4×	63 0.6×	100 1.3×	8 0.2×	18	227
E. K. W. Chiu China	6	82 0.6×	263 2.2×	32 0.3×	40 0.5×	18 0.5×	9	388
Fernando Campilho Portugal	11	87 0.6×	99 0.8×	49 0.5×	116 1.5×	38 1.1×	24	320

Countries citing papers authored by Luisa Verga

Since Specialization

Citations

This map shows the geographic impact of Luisa Verga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luisa Verga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luisa Verga more than expected).

Fields of papers citing papers by Luisa Verga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luisa Verga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luisa Verga. The network helps show where Luisa Verga may publish in the future.

Co-authorship network of co-authors of Luisa Verga

This figure shows the co-authorship network connecting the top 25 collaborators of Luisa Verga. A scholar is included among the top collaborators of Luisa Verga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luisa Verga. Luisa Verga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Randelli, Filippo, et al.. (2025). Efficacy of Ultrasound-Guided Injections of Type I Collagen-Based Medical Device for Greater Trochanteric Pain Syndrome: A Pilot Study. Life. 15(3). 366–366.

Criscuolo, Marianna, Luisa Verga, Francesco Marchesi, et al.. (2024). Revision of antifungal strategies definitions for invasive fungal infections (proven/probable/possible) in 461 patients with haematological malignancies (REDEFI‐SEIFEM). Mycoses. 67(8). e13781–e13781.

Benini, Annalisa, Francesca Bettini, Luisa Verga, et al.. (2023). Safety and Effectiveness of Intensive Treatments Administered Outside the Intensive Care Unit to Hematological Critically Ill Patients: An Intensive Care without Walls Trial. Journal of Clinical Medicine. 12(19). 6281–6281. 2 indexed citations

Menna, Pierantonio, Francesco Marchesi, Chiara Cattaneo, et al.. (2023). Posaconazole and midostaurin in patients with FLT3‐mutated acute myeloid leukemia: Pharmacokinetic interactions and clinical facts in a real life study. Clinical and Translational Science. 16(10). 1876–1885. 3 indexed citations

Criscuolo, Marianna, Nicola Fracchiolla, Francesca Farina, et al.. (2023). A review of prophylactic regimens to prevent invasive fungal infections in hematology patients undergoing chemotherapy or stem cell transplantation. Expert Review of Hematology. 16(12). 963–980.

Aroldi, Andrea, Luisa Verga, Giovanni Paolo Maria Zambrotta, et al.. (2022). A monocentric analysis of the long-term safety and efficacy of crizotinib in relapsed/refractory ALK+ lymphomas. Blood Advances. 7(3). 314–316. 11 indexed citations

Aroldi, Andrea, Lorenza Borin, Luisa Verga, et al.. (2022). Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID‐19 vaccine: A single‐center prospective observational study (NCT05074706). SHILAP Revista de lepidopterología. 3(4). 1201–1208. 3 indexed citations

Nadali, Gianpaolo, Anna Candoni, Chiara Cattaneo, et al.. (2020). Infections in patients with lymphoproliferative diseases treated with brentuximab vedotin: SEIFEM multicentric retrospective study. Leukemia & lymphoma. 61(12). 3002–3005. 1 indexed citations

Posteraro, Brunella, Elena De Carolis, Marianna Criscuolo, et al.. (2020). Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxis. Mycoses. 63(9). 900–910. 18 indexed citations

10.

Verga, Luisa, et al.. (2020). The spectrum of the cytopathological features of primary effusion lymphoma and human herpes virus 8‐related lymphoproliferative disorders. Cytopathology. 31(6). 541–546. 2 indexed citations

11.

Nadali, Gianpaolo, Francesca Farina, Maria Chiara Tisi, et al.. (2018). Infections in Patients with Lymphoproliferative Diseases Treated with Target Therapy. Italian Multicentric Retrospective Study Seifem 2017. Blood. 132(Supplement 1). 4164–4164. 5 indexed citations

12.

Ferreri, Andrés J.M., Michele Spina, Chiara Cattaneo, et al.. (2017). Safety and Activity of a Dose-Dense Short-Term Chemoimmunotherapy in HIV-Positive Patients with Burkitt Lymphoma (HIV-BL pts): Final Results of the Carmen Phase II Trial. Blood. 130. 2828–2828. 1 indexed citations

13.

Busca, Alessandro, Simone Cesaro, Luciana Teofili, et al.. (2017). SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disorders. Expert Review of Hematology. 11(2). 155–168. 4 indexed citations

14.

Cattaneo, Chiara, Patrizia Zappasodi, Valentina Mancini, et al.. (2016). Emerging resistant bacteria strains in bloodstream infections of acute leukaemia patients: results of a prospective study by the Rete Ematologica Lombarda (Rel). Annals of Hematology. 95(12). 1955–1963. 21 indexed citations

15.

Paolis, Maria Rosaria De, Stefan Hohaus, Vanessa Innao, et al.. (2014). Real-practice management and treatment of idiopathic multicentric Castleman disease with siltuximab: a collection of clinical experiences. Drugs in Context. 13. 1–14. 3 indexed citations

16.

Pagano, Livio, Luisa Verga, Alessandro Busca, et al.. (2014). Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey. Journal of Antimicrobial Chemotherapy. 69(11). 3142–3147. 16 indexed citations

17.

Cattaneo, Chiara, Suzanne M. de la Monte, Alessandra Algarotti, et al.. (2011). A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study). Journal of Antimicrobial Chemotherapy. 66(9). 2140–2145. 24 indexed citations

18.

Perseghin, Paolo, Elisabetta Terruzzi, Maria Dassi, et al.. (2009). Management of poor peripheral blood stem cell mobilization: Incidence, predictive factors, alternative strategies and outcome. A retrospective analysis on 2177 patients from three major Italian institutions. Transfusion and Apheresis Science. 41(1). 33–37. 69 indexed citations

19.

Rossini, Fausto, Elisabetta Terruzzi, Simona Cammarota, et al.. (2005). Cytomegalovirus infection after autologous stem cell transplantation: incidence and outcome in a group of patients undergoing a surveillance program. Transplant Infectious Disease. 7(3-4). 122–125. 28 indexed citations

20.

Rossini, Fausto, Elisabetta Terruzzi, Luisa Verga, et al.. (2004). A randomized clinical trial of ceftriaxone and amikacin versus piperacillin tazobactam and amikacin in febrile patients with hematological neoplasia and severe neutropenia. Supportive Care in Cancer. 13(6). 387–392. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact